NovoCure LimitedNVCRNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank25
3Y CAGR-3.6%
5Y CAGR-15.9%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-3.6%/yr
vs -4.8%/yr prior
5Y CAGR
-15.9%/yr
Recent acceleration
Acceleration
+1.3pp
Accelerating
Percentile
P25
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $103.39M | -36.9% |
| 2024 | $163.77M | -32.0% |
| 2023 | $240.82M | +108.8% |
| 2022 | $115.33M | -45.0% |
| 2021 | $209.61M | -14.9% |
| 2020 | $246.17M | +37.2% |
| 2019 | $179.42M | +27.6% |
| 2018 | $140.62M | +78.9% |
| 2017 | $78.59M | -21.2% |
| 2016 | $99.78M | - |